Timothy James Kinsella
#131,535
Most Influential Person Now
Timothy James Kinsella's AcademicInfluence.com Rankings
Timothy James Kinsellabiology Degrees
Biology
#8716
World Rank
#11841
Historical Rank
Cell Biology
#351
World Rank
#361
Historical Rank
Molecular Biology
#1132
World Rank
#1158
Historical Rank
Download Badge
Biology
Timothy James Kinsella's Degrees
- PhD Molecular Biology Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Timothy James Kinsella Influential?
(Suggest an Edit or Addition)Timothy James Kinsella's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes (2008) (2360)
- Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. (1993) (1060)
- A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. (1996) (506)
- Synthesis and Functional Analyses of Nuclear Clusterin, a Cell Death Protein* (2003) (403)
- Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. (1993) (357)
- Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. (1983) (345)
- Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. (1985) (338)
- Patterns of recurrence in patients with high-grade soft-tissue sarcomas. (1985) (326)
- The adverse effect of treatment prolongation in cervical carcinoma. (1995) (316)
- Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. (1987) (303)
- Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. (2000) (288)
- In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. (1983) (285)
- Defining the role of radiosurgery in the management of brain metastases. (1992) (282)
- High‐grade soft tissue sarcomas of the extremities (1986) (262)
- A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma (2006) (238)
- Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. (2001) (236)
- A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. (1997) (193)
- Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. (1984) (192)
- Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. (1992) (184)
- Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. (1998) (175)
- Rhabdomyosarcoma. A new classification scheme related to prognosis. (1992) (173)
- Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. (1993) (171)
- Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. (1995) (170)
- Photodynamic therapy: a new concept in medical treatment. (2000) (169)
- Tolerance of the intestine to radiation therapy. (1980) (164)
- Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs. (1987) (151)
- Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. (2008) (150)
- Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. (1985) (149)
- Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. (1988) (147)
- Photodynamic therapy/Oncology (2001) (138)
- Glutathione elevation during thermotolerance induction and thermosensitization by glutathione depletion. (1983) (134)
- Preliminary results of a randomized study of adjuvant radiation therapy in resectable adult retroperitoneal soft tissue sarcomas. (1988) (128)
- Tolerance of peripheral nerve to intraoperative radiotherapy (IORT): clinical and experimental studies. (1984) (126)
- High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. (1992) (125)
- A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk (1985) (116)
- Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors. (1984) (115)
- The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers. (1984) (115)
- Treatment of peripheral neuroepithelioma in children and young adults. (1987) (113)
- Mammalian target of rapamycin and S6 kinase 1 positively regulate 6-thioguanine-induced autophagy. (2008) (112)
- Principles of Radiation Oncology (2003) (107)
- Effects of fractionated irradiation of endocrine aspects of testicular function. (1985) (107)
- Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. (1988) (107)
- Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells. (2001) (106)
- Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy. (1991) (106)
- Experimental and clinical studies with intraoperative radiotherapy. (1983) (106)
- Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease. (1989) (105)
- Isolation of Ku70-binding proteins (KUBs). (1999) (102)
- Minimization of small bowel volume within treatment fields utilizing customized "belly boards". (1990) (102)
- CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation. (2005) (100)
- Coordination of DNA Mismatch Repair and Base Excision Repair Processing of Chemotherapy and Radiation Damage for Targeting Resistant Cancers (2009) (97)
- A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation. (1984) (97)
- Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients. (2009) (96)
- DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells. (2003) (95)
- Threshold dose for peripheral neuropathy following intraoperative radiotherapy (IORT) in a large animal model. (1991) (94)
- Randomized trial of intraoperative radiotherapy in carcinoma of the stomach. (1993) (92)
- Phase I Trial of Pelvic Radiation, Weekly Cisplatin, and 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, NSC #663249) for Locally Advanced Cervical Cancer (2010) (87)
- Peripheral dose to the testes: the design and clinical use of a practical and effective gonadal shield. (1985) (84)
- Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization. (2003) (83)
- Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation. (2001) (83)
- A phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer. (1985) (81)
- Studies of intraoperative radiotherapy in carcinoma of the pancreas. (1999) (81)
- Pathological Tissue Changes Following Intraoperative Radiotherapy (1986) (80)
- Clinical pharmacology of 5‐iodo‐2′‐deoxyuridine and 5‐iodouracil and endogenous pyrimidine modulation (1985) (79)
- Randomized trial of intraoperative radiotherapy in resected carcinoma of the pancreas (1986) (78)
- Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: final report of RTOG 86-12, Phase I-II study. (1996) (76)
- Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. I. Radiosensitization of human colon cancer cells by iododeoxyuridine. (1992) (75)
- Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer. (1984) (75)
- Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: six months of intensive combined modality therapy without maintenance. (1988) (75)
- The Impact of Resection Margin Status and Postoperative CA19-9 Levels on Survival and Patterns of Recurrence After Postoperative High-Dose Radiotherapy With 5-FU—Based Concurrent Chemotherapy for Resectable Pancreatic Cancer (2008) (75)
- Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint. (2003) (75)
- Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR). (1983) (71)
- DNA Mismatch Repair Initiates 6-Thioguanine–Induced Autophagy through p53 Activation in Human Tumor Cells (2007) (71)
- Radiosensitization by fluorodeoxyuridine: effects of thymidylate synthase inhibition and cell synchronization. (1992) (71)
- Increased thymidylate synthase protein levels are principally associated with proliferation but not cell cycle phase in asynchronous human cancer cells. (1995) (69)
- High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations. (1992) (69)
- Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma. (1996) (68)
- Extremity preservation by combined modality therapy in sarcomas of the hand and foot: an analysis of local control, disease free survival and functional result. (1983) (68)
- When X-ray-inducible proteins meet DNA double strand break repair. (2001) (67)
- Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial. (1997) (67)
- Breast Conservation Surgery Achieving ≥ 2 mm Tumor‐Free Margins Results in Decreased Local‐Regional Recurrence Rates (2006) (67)
- Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway occlusion. (1992) (66)
- National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma. (1994) (64)
- Normal tissue tolerance to intraoperative radiotherapy. (2003) (64)
- Is neuro-ectodermal differentiation of Ewing's sarcoma of bone associated with an unfavourable prognosis? (1995) (63)
- Prognostic value of histopathology in ewing's sarcoma. Long‐term follow‐up of distal extremity primary tumors (1991) (63)
- Extraskeletal Ewing's sarcoma: results of combined modality treatment. (1983) (63)
- Intraoperative radiation therapy at the National Cancer Institute: technical innovations and dosimetry. (1985) (62)
- Inguinofemoral radiation of N0,N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation technique is used. (1993) (62)
- Treatment of arteriovenous malformations with stereotactic radiosurgery employing both magnetic resonance angiography and standard angiography as a database. (1993) (61)
- Extremity soft tissue sarcomas: Analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher‐grade sarcomas (1989) (61)
- Endobronchial irradiation for malignant airway obstruction. (1989) (60)
- A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma. (1994) (60)
- Quality of coverage: Conformity measures for stereotactic radiosurgery (2003) (59)
- Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy. (1991) (58)
- Ribonucleotide Reductase Inhibition Enhances Chemoradiosensitivity of Human Cervical Cancers (2010) (57)
- Radioimmunoguided imaging of prostate cancer foci with histopathological correlation. (2001) (56)
- The use of non-hypoxic cell sensitizers in radiobiology and radiotherapy. (1986) (56)
- Monte Carlo and convolution dosimetry for stereotactic radiosurgery. (1990) (55)
- Clinical experience with intravenous radiosensitizers in unresectable sarcomas (1987) (55)
- Oral management of patients following oncology treatment: literature review. (2000) (54)
- The DNA N-glycosylase MED1 exhibits preference for halogenated pyrimidines and is involved in the cytotoxicity of 5-iododeoxyuridine. (2006) (51)
- Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells. (1998) (51)
- Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation. (1996) (50)
- Halogenated Pyrimidines as Radiosensitizers in the Treatment of Glioblastoma Multiforme (1987) (50)
- CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses. (2004) (48)
- Enhancement of radiation damage in cellular DNA following unifilar substitution with iododeoxyuridine. (1990) (48)
- In vitro X-ray sensitivity in ataxia telangiectasis homozygote and heterozygote skin fibroblasts under oxic and hypoxic conditions. (1982) (47)
- Are complications in intraoperative radiation therapy more frequent than in conventional treatment? (1989) (47)
- Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chk1 pathway. (2004) (47)
- Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo. (1994) (47)
- Tolerance of the canine bladder to intraoperative radiation therapy: an experimental study. (1988) (47)
- Combined modality treatment of adult soft tissue sarcomas of the head and neck. (1987) (47)
- Single biopsy, tumor kinetic analyses: a comparison of methods and an extension to shorter sampling intervals. (1992) (47)
- Late effects of intraoperative radiation therapy on retroperitoneal tissues, intestine, and bile duct in a large animal model. (1994) (46)
- Extraosseous Ewing's sarcoma: 25 years later. (2008) (46)
- BNIP3 is Essential for Mediating 6-thioguanine-and 5-fluorouracil-induced Autophagy Following DNA Mismatch Repair Processing (2010) (45)
- Targeting DNA mismatch repair for radiosensitization. (2001) (45)
- Modulating Radiation Resistance by Inhibiting Ribonucleotide Reductase in Cancers with Virally or Mutationally Silenced p53 Protein (2009) (45)
- A three-dimensional volume visualization package applied to stereotactic radiosurgery treatment planning. (1991) (44)
- Late effects of radiation therapy in the treatment of Hodgkin's disease. (1982) (44)
- Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver (1988) (44)
- Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR. (1984) (43)
- Treatment of sarcomas of the chest wall using intensive combined modality therapy. (1989) (43)
- Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol. (1995) (43)
- Tumor induction following intraoperative radiotherapy: late results of the National Cancer Institute canine trials. (1990) (42)
- Response of the mediastinal and thoracic viscera of the dog to intraoperative radiation therapy (IORT). (1987) (42)
- Paclitaxel Poliglumex, Temozolomide, and Radiation for Newly Diagnosed High-grade Glioma: A Brown University Oncology Group Study (2014) (42)
- An approach to the radiosensitization of human tumors. (1996) (41)
- Surgical approaches and techniques in intraoperative radiotherapy for intra-abdominal, retroperitoneal, and pelvic neoplasms. (1988) (41)
- Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine. (2000) (41)
- Real-time inverse planning for Gamma Knife radiosurgery. (2003) (41)
- Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G1 restriction point into S-phase: implications for fluoropyrimidine radiosensitization. (2000) (41)
- Quality control parameters of intraoperative radiation therapy. (1986) (41)
- Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors. (1996) (41)
- The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization. (1994) (41)
- Stage II endometrial carcinoma: 10-year follow-up of combined radiation and surgical treatment. (1980) (41)
- Casein Kinase 2 Regulates Both Apoptosis and the Cell Cycle Following DNA Damage Induced by 6-Thioguanine (2005) (40)
- Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator. (2004) (40)
- Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12). (1993) (40)
- Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer. (1995) (40)
- The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells. (1999) (40)
- Essential role of DNA base excision repair on survival in an acidic tumor microenvironment. (2009) (39)
- A phase I study of intraarterial iododeoxyuridine in patients with colorectal liver metastases. (1989) (39)
- Prospective study of nutritional support during pelvic irradiation. (1981) (38)
- BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage. (2007) (37)
- Radiation induced thyroid neoplasms 1920 to 1987: a vanishing problem? (1989) (37)
- Thyroid nodules after high-dose external radiotherapy. Fine-needle aspiration cytology in diagnosis and management. (1982) (36)
- Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma. (2003) (36)
- Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients. (1983) (36)
- Repair of ionizing radiation DNA base damage in ataxia-telangiectasia cells. (1986) (35)
- Methoxyamine potentiates iododeoxyuridine-induced radiosensitization by altering cell cycle kinetics and enhancing senescence (2006) (35)
- The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation. (1992) (35)
- Angiosarcoma of the Head and Neck Managed by a Combination of Multiple Biopsies to Determine Tumor Margin and Radiation Therapy: Report of Three Cases and Review of the Literature (1998) (35)
- Local treatment of Ewing's sarcoma: radiation therapy versus surgery. (1984) (34)
- Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974–2011 (2016) (34)
- Concomitant hepatic radiation and intraarterial fluorinated pyrimidine therapy: Correlation of liver scan, liver function tests, and plasma CEA with tumor response (1981) (33)
- Differential Radiosensitization in DNA Mismatch Repair-Proficient and -Deficient Human Colon Cancer Xenografts with 5-Iodo-2-pyrimidinone-2′-deoxyribose (2004) (33)
- Repeat Stereotactic Radiosurgery for Locally Recurrent Brain Metastases. (2017) (32)
- A Retrospective Review of Nodal Treatment for Vulvar Cancer (1993) (32)
- Clinical toxicity of peripheral nerve to intraoperative radiotherapy in a canine model. (1995) (32)
- Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies. (1989) (31)
- Resource Utilization: High Dose Rate Versus Low Dose Rate Brachytherapy for Gynecologic Cancer (1993) (31)
- In vitro radiation studies on Ewing's sarcoma cell lines and human bone marrow: application to the clinical use of total body irradiation (TBI). (1984) (31)
- Surgery with intraoperative radiotherapy for sarcomas of the pelvic girdle: a pilot experience. (1988) (31)
- Delivery of intraoperative radiation therapy after pneumonectomy: experimental observations and early clinical results. (1987) (30)
- An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116. (1994) (30)
- The clinical rationale for S-phase radiosensitization in human tumors. (1993) (29)
- Analysis of the effect of DNA alkylation on alkaline elution. (1986) (29)
- Histopathological effects of intraoperative radiotherapy on pancreas and adjacent tissues: A postmortem analysis (1988) (29)
- Intraoperative radiotherapy for pancreatic carcinoma: Experimental and clinical studies (1996) (29)
- A Novel Role for DNA Mismatch Repair and the Autophagic Processing of Chemotherapy Drugs in Human Tumor Cells (2007) (29)
- Incorporation of iododeoxyuridine into DNA of granulocytes in patients. (1986) (28)
- Effects of intraoperative radiotherapy on vascular grafts in a canine model. (1994) (28)
- In vivo dosimetry using a single diode for megavoltage photon beam radiotherapy: Implementation and response characterization (2001) (28)
- Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy. (2000) (28)
- Cavernous sinus cranial neuropathies: is there a dose-response relationship following radiosurgery? (1993) (28)
- Overexpression of the R2 Subunit of Ribonucleotide Reductase in Human Nasopharyngeal Cancer Cells Reduces Radiosensitivity (2003) (28)
- Tumors in dogs exposed to experimental intraoperative radiotherapy. (1996) (28)
- Cellular and Molecular Responses to Topoisomerase I Poisons: Exploiting Synergy for Improved Radiotherapy (2000) (27)
- Dose intensification in curative head and neck cancer radiotherapy--linear quadratic analysis and preliminary assessment of clinical results. (1993) (27)
- Comparison of Helical Tomotherapy versus Conventional Radiation to Deliver Craniospinal Radiation (2008) (27)
- Evaluation of incorporated iododeoxyuridine cellular radiosensitization by photon activation therapy. (1987) (27)
- Experimental and clinical studies of intraoperative radiation therapy. (1994) (26)
- Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study. (1988) (26)
- Response of canine esophagus to intraoperative electron beam radiotherapy. (1988) (26)
- Adriamycin cardiotoxicity in stage IV breast cancer: possible enhancement with prior left chest radiation therapy. (1979) (26)
- A correction method for high-count-rate quantitative radionuclide angiography. (1972) (25)
- Preliminary Clinical and Pharmacologic Investigation of Photodynamic Therapy with the Silicon Phthalocyanine Photosensitizer Pc 4 for Primary or Metastatic Cutaneous Cancers (2011) (25)
- Chemical Modification of Radiation and Chemotherapy (1988) (25)
- Treatment of pelvic sarcomas in adolescents and young adults with intensive combined modality therapy. (1987) (25)
- The application of correlated sampling to the computation of electron beam dose distributions in heterogeneous phantoms using the Monte Carlo method. (1993) (24)
- A solid water pelvic and prostate phantom for imaging, volume rendering, treatment planning, and dosimetry for an RTOG multi-institutional, 3-D dose escalation study. Radiation Therapy Oncology Group. (1998) (24)
- Advances in radiation therapy for head and neck cancer (1995) (24)
- The role of radiation therapy alone and combined with infusion chemotherapy for treating liver metastases. (1983) (24)
- Thoracic volume radiation sparing following endobronchial brachytherapy: a quantitative analysis. (1993) (24)
- Keynote address: integration of cytostatic agents and radiation therapy: a different approach to "proliferating" human tumors. (1991) (24)
- Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases (2018) (23)
- Intensive combined modality therapy of small round cell and undifferentiated sarcomas in children and young adults: local control and patterns of failure. (1989) (23)
- Impact of Autophagy on Chemotherapy and Radiotherapy Mediated Tumor Cytotoxicity: “To Live or not to Live” (2011) (23)
- Global comparison of radiation and chemotherapy dose-response curves with a test for interaction. (1993) (23)
- History, preliminary results, complications, and future prospects of intraoperative radiotherapy (1987) (23)
- Small-cell osteosarcoma: correlation of in vitro and clinical radiation response. (1988) (23)
- Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues. (1998) (23)
- Determinants of radiosensitivity. (1985) (23)
- Preclinical study of the systemic toxicity and pharmacokinetics of 5-iodo-2-deoxypyrimidinone-2'-deoxyribose as a radiosensitizing prodrug in two, non-rodent animal species: implications for phase I study design. (2000) (22)
- Alzheimer's disease fibroblasts have normal repair of N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA damage determined by the alkaline elution technique. (1987) (22)
- Effects of radiation therapy and chemotherapy on testicular function. (1989) (22)
- Ribonucleotide Reductase Inhibitors: A New Look at an Old Target for Radiosensitization (2012) (22)
- Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. II. Radiosensitization of human colon cancer cells by bromodeoxyuridine. (1992) (22)
- TBI treatment planning using the ADAC pinnacle treatment planning system. (2000) (22)
- Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study. (2004) (22)
- Differential Cellular Responses to Prolonged LDR-IR in MLH1-Proficient and MLH1-Deficient Colorectal Cancer HCT116 Cells (2009) (21)
- Predictors for Long-Term Survival Free from Whole Brain Radiation Therapy in Patients Treated with Radiosurgery for Limited Brain Metastases (2015) (21)
- New radiosensitizing regimens, drugs, prodrugs, and candidates. (2004) (21)
- Long term tolerance of thoracic organs to intraoperative radiotherapy. (1992) (20)
- Radiosensitization and cell kinetics: clinical implications for S-phase-specific radiosensitizers. (1992) (20)
- Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine radiosensitization in U251 human glioblastoma xenografts. (2000) (20)
- Magnetic resonance angiography: a three-dimensional database for assessing arteriovenous malformations. Technical note. (1993) (20)
- Normal tissue tolerance to intraoperative radiation therapy. Experimental and clinical studies. (1989) (19)
- Extraskeletal ewing's sarcoma: results of combined modality treatment (1981) (19)
- Hemipelvectomy and intraoperative radiotherapy for bone and soft tissue sarcomas of the pelvic girdle. (1995) (18)
- Heterogeneous response to X-ray and ultraviolet light irradiations of cultured skin fibroblasts in two families with Gardner's Syndrome. (1982) (18)
- Damage‐Sensing mechanisms in human cells after ionizing radiation (1997) (18)
- Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics. (2009) (18)
- Mobile linear accelerators for intraoperative radiation therapy. (2001) (18)
- Combined modality therapy (1991) (17)
- Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells. (1990) (17)
- Treatment of high-risk sarcomas in children and young adults: analysis of local control using intensive combined modality therapy. (1988) (17)
- Radiation Therapy in Addition to Gross Total Resection of Retroperitoneal Sarcoma Results in Prolonged Survival: Results from a Single Institutional Study (2009) (17)
- Clinical results of intraoperative radiation therapy for patients with locally recurrent and advanced tumors having colorectal involvement. (2008) (17)
- Potentiation of chemotherapy cytotoxicity following iododeoxyuridine incorporation in Chinese hamster cells. (1986) (17)
- Regularization of inverse planning for intensity-modulated radiotherapy. (2005) (16)
- Intraoperative Electron Radiotherapy for Extremity Sarcomas Does Not Increase Acute or Late Morbidity (2006) (16)
- Repair of gamma-ray-induced DNA base damage in xeroderma pigmentosum cells. (1986) (16)
- The interaction between two radiosensitizers: 5-iododeoxyuridine and caffeine. (2006) (15)
- Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis (2015) (15)
- National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer (2019) (15)
- Identification of bromodeoxyuridine in malignant and normal cells following therapy: relationship to complications. (1984) (15)
- Tumor cell kinetics using two labels and flow cytometry. (1994) (14)
- Intraoperative radiation therapy-induced sarcomas in dogs. (1989) (14)
- Continuous infusion of halogenated pyrimidines. (1991) (14)
- 1002 An analysis of acute complications and perioperative morbidity from high dose rate brachytherapy in the treatment of gynecological malignancies (1995) (14)
- Modulation of the activity of methyl binding domain protein 4 (MBD4/MED1) while processing iododeoxyuridine generated DNA mispairs (2009) (14)
- Role of MutSα in the Recognition of Iododeoxyuridine in DNA (2003) (14)
- A new approach to intraoperative radiation therapy. (2001) (13)
- Role of MutSalpha in the recognition of iododeoxyuridine in DNA. (2003) (13)
- Combining polyamine depletion with radiation therapy for rapidly dividing head and neck tumors: strategies for improved locoregional control. (1994) (13)
- The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells. (1995) (13)
- Update on radiosensitization by halogenated thymidine analogs-molecular mechanisms of drug processing and cell death signaling: Implications for future clinical trials (2008) (12)
- Clinical Evaluation of a Gamma Knife Inverse Planning System (2004) (12)
- Early experience with intraoperative radiotherapy in patients with resected pancreatic adenocarcinoma. (2008) (12)
- Radiation oncologists can assist head and neck cancer patients with smoking cessation. (1995) (12)
- Iododeoxyuridine radiosensitization of human glioblastoma cells exposed to acute and chronic gamma irradiation: mechanistic implications and clinical relevance. (1995) (12)
- Normal Tissue Tolerance to Intraoperative Irradiation (1999) (12)
- Tolerance of the bladder to intraoperative radiation in a canine model: a five-year follow-up. (1994) (12)
- Halogenated pyrimidines as radiosensitizers for high grade glioma: revisited. (1991) (12)
- Probabilistic modeling of DNA mismatch repair effects on cell cycle dynamics and iododeoxyuridine-DNA incorporation. (2007) (12)
- Primary squamous cell carcinoma of the main hepatic bile duct. (2008) (12)
- 5-iodo-2-pyrimidinone-2'-deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts. (2007) (11)
- IPdR: a novel oral radiosensitizer (2007) (11)
- Radiation therapy for renal transplant rejection refractory to pulse steroids and OKT3. (1996) (11)
- Role of combined-modality therapy in the curative management of advanced-stage "favorable" non-Hodgkin's lymphomas. (1982) (11)
- Modulation of X ray DNA damage by SR-2508 +/- buthionine sulfoximine. (1986) (11)
- Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines. (2000) (11)
- Television system for verification and documentation of treatment fields during intraoperative radiation therapy. (1983) (11)
- Role of the hMLH 1 DNA Mismatch Repair Protein in Fluoropyrimidine-mediated Cell Death and Cell Cycle Responses 1 (2001) (10)
- Optimizing the dose rate and technique in cervical carcinoma--balancing cases versus complications. (1994) (10)
- Intraoperative radiotherapy in the multimodality approach to bone and soft tissue cancers. (2003) (10)
- Alternative techniques of intraoperative radiotherapy. (2000) (10)
- Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study. (1996) (9)
- Staging laparotomy and splenectomy for Hodgkin's disease: current status. (1983) (9)
- The interaction of hydroxyurea and ionizing radiation in human cervical carcinoma cells. (1997) (9)
- Patients with Long-Term Control of Systemic Disease Are a Favorable Prognostic Group for Treatment of Brain Metastases with Stereotactic Radiosurgery Alone. (2016) (9)
- Hepatic irradiation in the management of metastatic hormone‐secreting tumors (1985) (9)
- Limited surgery and radiation therapy for sarcomas of the hand and foot. (1986) (9)
- A phase II study of complete neoadjuvant therapy in rectal cancer (CONTRE): The Brown University Oncology Group. (2013) (9)
- Interaction of iododeoxyuridine and its primary metabolite, iodouracil on radiation response. (1986) (9)
- Cost Analysis of Radiosurgery versus Resection for Single Brain Metastases (1996) (9)
- Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2′deoxyribose (IPdR) × 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization (2007) (8)
- 90Y.B72.3 against pancreatic cancer: dosimetric and biological analysis. (1990) (8)
- DNA Mismatch Repair ( MMR ) Mediates 6-Thioguanine Genotoxicity by Introducing Single-strand Breaks to Signal a G 2M Arrest in MMR-proficient RKO Cells 1 (2003) (8)
- Tumor cell kinetics in mixed populations. (1994) (8)
- Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure. (1984) (8)
- In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts. (1996) (8)
- Modulation of proliferation kinetics in human squamous cell carcinomas of the head and neck. (1993) (8)
- The limiting radiosensitisation of tumours by S-phase sensitisers. (1996) (8)
- Transcriptional Responses to Damage Created by Ionizing Radiation (1998) (7)
- Overexpression of a hexa-histidine and T7 peptide-tagged human ribonucleotide reductase small subunit, R2 in Escherichia coli and the generation of human R2 antibodies. (1997) (7)
- In vivo incorporation of bromodeoxyuridine into proliferating cells in the marrow and its effects on granulocyte-macrophage progenitor cells. (1985) (7)
- A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer (2013) (7)
- Stereotactic radiosurgery improves survival in malignant gliomas compared with the RTOG recursive partitioning analysis (1994) (6)
- Alzheimer's Disease Fibroblasts Have Normal Repair of Methylmethane Sulfonate-induced DNA Damage Determined by the Alkaline Elution Technique (1987) (6)
- Standardized treatment planning for high dose rate vaginal cuff brachytherapy (1995) (6)
- Schedule-dependent drug effects of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as an in vivo radiosensitizer in U251 human glioblastoma xenografts. (2005) (6)
- Adjuvant radiation therapy in pancreatic carcinoma: a reappraisal. (1988) (6)
- Normal-Tissue Tolerance to IOERT, EBRT, or Both: Animal and Clinical Studies (2011) (6)
- Adjuvant therapy for rectal cancer. (2007) (6)
- Concomitant hepatic radiation and intraarterial fluorinated pyrimidine therapy: correlation of liver scan, liver function tests, and plasma CEA with tumor response. (1981) (6)
- Schedule-Dependent Drug Effects of Oral 5-Iodo-2-Pyrimidinone-2′-Deoxyribose as an In vivo Radiosensitizer in U251 Human Glioblastoma Xenografts (2005) (6)
- Radiation Oncology: Today and Tomorrow (2011) (6)
- Effects of bleomycin with iododeoxyuridine, 5'-amino-5'-deoxythymidine, and radiation in a human bladder cancer cell line. (1993) (5)
- Comparable Tumor Responses and Acute/Late Normal Tissue Toxicities with Standard Combined Modality Treatment for Anal Squamous Cell Carcinomas in HIV+ and HIV− Patients (2005) (5)
- Complete neoadjuvant therapy in rectal cancer (CONTRE): A Brown University Oncology Research Group phase II study. (2014) (5)
- Transcriptional Responses to Damage Created by Ionizing Radiation: Molecular Sensors (1998) (5)
- A conceptual modeling framework for the study of DNA mismatch repair pathway to improve therapeutic gain in cancer treatment (2007) (5)
- Measurement of DNA polymerase beta in skin fibroblast cell lines from patients with ataxia telangiectasia. (1985) (5)
- An analysis of the efficacy and safety of high dose rate as compared to low dose rate brachytherapy in the treatment of uterine cervical carcinoma (1993) (5)
- Clinical Study of Using Biometrics to Identify Patient and Procedure (2020) (4)
- Minimization of small bowel volume utilizing customized “Belly Board” mold (1989) (4)
- Photon activation therapy (PAT) (1987) (4)
- Preliminary results of a prospective randomized trial of intraoperative (IORT) and low dose external beam radiotherapy vs high dose external beam radiotherapy as adjunctive therapy in resectable soft tissue sarcomas of the retroperitoneum (1986) (4)
- Developing an in silico model of the modulation of base excision repair using methoxyamine for more targeted cancer therapeutics. (2013) (4)
- Integration of Principles of Systems Biology and Radiation Biology: Toward Development of in silico Models to Optimize IUdR-Mediated Radiosensitization of DNA Mismatch Repair Deficient (Damage Tolerant) Human Cancers (2011) (4)
- A Rapid, Simple DNA Mismatch Repair Substrate Construction Method (2011) (3)
- 9 Continuous 28 day iododeoxyuridine (IUdR) infusion and hyperfractionated accelerated radiotherapy (HART) for malignant glioma: A phase I clinical and thymidine replacement study (1997) (3)
- Computed tomographic evaluation of radiation pneumonitis in a canine model. (1998) (3)
- Proceeding of the 37th Annual ASTRO meeting Abstract of scientific paper to be persented8 A multi-institutional outcome and prognostic factor analysis of radiosurgery (RS) for resectable single brain metastasis (1995) (3)
- Intraoperative radiotherapy — Current status — 1992 (1992) (3)
- Abstracts of ASTRO scientific papers to be presentedThe adverse effect of treatment prolongation in cervical carcinoma (1993) (3)
- Stereotactic radiation: Evaluation of brain tumor response (1990) (3)
- Selective radiosensitization of drug-resistant MSH2 mismatch repair-deficient cells by halogenated thymidine (DTHD) analogs (2000) (3)
- Quantitative analysis of the effects of iododeoxyuridine and ionising radiation treatment on the cell cycle dynamics of DNA mismatch repair deficient human colorectal cancer cells. (2013) (3)
- 110 Phase II clinical trial of amifostine (WR2721), cisplatin (C), vinblastine (V) (ACV) and thoracic radiation therapy (RT) for unresectable stage III non small cell lung cancer (NSCLC). (1995) (3)
- New therapeutic strategies in radiation therapy. (1981) (3)
- Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells. (1994) (3)
- 1041 Leucovorin (LV) modulation of iododeoxyuridine (IdUrd) radiosensitization; A phase I study (1995) (3)
- Modifications of the delayed biopsy technique for human tumor proliferation kinetics (1991) (3)
- The use of prolonged constant intravenous infusions of bromodeoxyuridine (BUdR) as a radiosensitizer (1984) (2)
- Updates in Molecular Pathology of Central Nervous System Gliomas in Adults. (2015) (2)
- Glioblastoma treated with external beam radiotherapy and stereotactic radiosurgery boost (1993) (2)
- 4th International Conference on Dose, Time and Fractionation in Radiation Oncology, at the University of Wisconsin, Madison, WI, USA, 16-19 September 1992. (1993) (2)
- Intraoperative radiotherapy for pancreatic carcinoma: Experimental and clinical studies (2)
- Patients With Long-term Control of Systemic Disease Are a Favorable Prognostic Group for Treatment of Brain Metastases With SRS Alone (2015) (2)
- 2025 Cost analysis of alternate management schemes in early stage testicular seminoma (1995) (2)
- Abstract of ASTRO Scientific paper to be presentedPhase I study of intravenous infusions of iododeoxyuridine (IUdR) as a clinical radiosensitizer (1984) (2)
- Cell cycle redistribution by fluorodeoxyuridine (fdurd) as a mechanism of fluoropyrmiidine radiosensttization. Supported by an ASTRO Research Fellowship (1993) (2)
- Analysis of cell cycle dynamics using probabilistic cell cycle models (2011) (2)
- An improved ray casting technique for surface-shaded display: applications in radiation treatment planning (1989) (2)
- Tolerance of vascular grafts to intraoperative radiotherapy in a canine model (1993) (2)
- Soft tissue tumor induction following intraoperative radiotherapy (IORT): late results of the nci canine trials (1989) (2)
- An estimate of the perturbing effect of Cerenkov radiation to the signal from a liquid scintillator volume irradiated by a megavoltage photon beam (2000) (2)
- Dosimetric Accuracy of Ray-tracing Algorithm for Treatment of Thoracic Spine Lesions Using Robotic Radiosurgery (2012) (2)
- 125Iodine interstitial brachytherapy for primary malignant brain tumors. a phase I–II study (1987) (2)
- Basic techniques and principles of intraoperative radiotherapy (1987) (2)
- 1010 High dose rate brachytherapy for medically inoperable stage I endometrial cancer (1995) (2)
- Radioimmunotherapy: dosimetric and biological analysis (1989) (1)
- Methoxyamine potentiates iododeoxyuridine-induced radiosensitization not through increasing ionizing radiation-induced apoptosis and necrosis but through enhancing senescence (2005) (1)
- 129 Potentiation of radiation lethality by topotecan, a topoisomerase 1 inhibitor (1995) (1)
- The role of magnetic resonance angiography in the radiosurgical management of arteriovenous malformations (1991) (1)
- Simple numerical system for scoring the cosmetic effects of radiation and surgery post‐conservation therapy for breast cancer (1994) (1)
- Phase I–II study of iododeoxyuridine (IUdR) and radiotherapy in the treatment of malignant glioma (RTOG 86-12) (1992) (1)
- The roles of mammalian target of rapamycin (mTOR) and p21 in the autophagy pathway after DNA mismatch repair processing of 6-thioguanine (2007) (1)
- Treatment approaches in soft tissue sarcomas--putting our best foot forward. (1990) (1)
- Pelvic implantation with three-dimensional, computed tomography-based preplanning (1990) (1)
- Post-operative high dose rate vaginal cuff irradiation: A phase I-II Protocol (1994) (1)
- Direct computerized tomographic (CT) dosimetry of endobronchial implants (1989) (1)
- Trends in the Use of Radiation Therapy for Pediatric T-Cell Acute Lymphoblastic Leukemia and Impact on Survival: A Population-Based Analysis (2016) (1)
- 2333 : Triapine Radiosensitization of Cervical Cancer Through Inhibition of Ribonucleotide Reductase (2006) (1)
- Correlation of post-radiosurgical histopathology with radiographic changes (1993) (1)
- Using intraoperative radiation therapy--a case study. (2003) (1)
- Intraoperative radiation therapy for locally advanced cancers. (1989) (1)
- Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation (2019) (1)
- Effect of a pure anti‐estrogen, ICI 182,780, on the in vitro radiosensitivity of MCF‐7 breast carcinoma cells (1995) (1)
- P38 05 TP – IODODEOXYURIDINE: A MORE EFFICIENT RADIOSENSITIZER THAN BROMODEOXYURIDINE IN THE CLINICALLY-RELEVANT PORTION OF THE RADIATION SURVIVAL CURVE OF HUMAN CELLS (1991) (1)
- S-PHASE SPECIFIC RADIOSENSITIZERS: NEW EXPERIMENTAL AND CLINICAL APPROACHES TO OVERCOME TUMOR CELL REPOPULATION (1992) (1)
- Low pH does not affect the dose response for 5'-amino-5'-deoxythymidine modulation of IdUrd DNA incorporation and radiosensitization in a human bladder cancer cell line. (1992) (1)
- Is inguino-femoral irradiation as effective as lymphadenectomy for N0, N1 vulvar disease? (1992) (1)
- Improving Patient Selection for Stereotactic Radiosurgery as the Initial Radiation Therapy Approach for Brain Metastases (2014) (1)
- Early intervention with combined modality therapy for ‘favorable’ non-Hodgkin’s lymphomas of advanced stage (1983) (0)
- Intraoperative radiotherapy - Current status -1993 (1993) (0)
- Advances in Brief Both DNA Topoisomerase II-binding Protein 1 and BRCA 1 Regulate the G 2M Cell Cycle Checkpoint 1 (2003) (0)
- Performance evaluation of a plastic scintillation detector for the measurement of electron dose distributions near an inhomogeneity (1992) (0)
- What's new in radiation oncology. (1997) (0)
- Early S-phase delay by fluorodeoxyuridine (FdUrd) as a mechanism of fluoropyrimidine radiosensitization (1992) (0)
- Physics considerations in conversion from low dose rate to high dose rate gynecological intracavitory radiotherapy (1990) (0)
- Cost comparison of radiosurgery and surgery for treatment of brain metastasis (1994) (0)
- Locally recurrent disease following combined modality treatment of high-grade soft tissue sarcomas (1984) (0)
- P28 21 WP – MODULATION OF IODODEOXYURIDINE ENHANCED BLEOMYCIN CYTOTOXICITY AND DNA DAMAGE BY 5'-AMINO-5'-DEOXYTHYMIDINE AND RADIATION (1991) (0)
- The Sun Has Not Yet Set on WBRT (2016) (0)
- Morphological Variants Cell Lines of Human Small Cell Lung Cancer and Its Large Cell Radiation and Chemotherapy Sensitivity of Established In Vitro Updated (2006) (0)
- Schedule-dependency and cell cycle redistribution of HT29 cells in response to fluoropyrimidines (1993) (0)
- Radiosensitization of Nonhypoxic Cells by Halogenated Pyrimidines (1991) (0)
- The structure of iort in the united states, and clinical trials of its efficacy in RTOG (1987) (0)
- Late effects of intraoperative irradiation on retroperitoneal tissues, intestine, and bile duct (1987) (0)
- Intraoperative radiotherapy. (1985) (0)
- Comparison of Fractionated Stereotactic Radiosurgery and Single-Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases (2014) (0)
- 170 Feasibility study of using an industrial hand-held optical scanner for image-guided radiation therapy (2006) (0)
- Commentary (Kinsella): Current Status of Radiation Sensitization by Fluoropyrimidines (1995) (0)
- Lung cysts. (1948) (0)
- Impact on surgical outcomes of complete neoadjuvant treatment of rectal cancer (CONTRE) (2014) (0)
- Abstracts of ASTRO scientific papers to be presentedTomotherapy: Inverse treatment planning for conformal radiotherapy (1993) (0)
- Soft tissue sarcoma: combined modality approaches. (1993) (0)
- Essential Role of DNA Base Excision Repair on Survival in an Acidic Tumor Microenvironment (2008) (0)
- Intraoperative radiotiierapy — current status — 1991 (1991) (0)
- Intensive combined modality treatment with autologous marrow infusion in high risk ewing's sarcoma patients (1981) (0)
- Kinetics of IdUrd incorporation after continuous exposure in-vivo☆ (1991) (0)
- Response to editorial by Drs. Lanciano and corn (1993) (0)
- A phase I RTOG study of idodeoxyuridine (IUdR) and radiotherapy in the treatment of primary malignant brain (1989) (0)
- DNA Mismatch Repair: Its Role in Human Carcinogenesis and as a Predictive and/or Prognostic Biomarker for Cancer Therapy (2013) (0)
- 83 Patterns of failure in CCG 921, a phase III study of chemoradiotherapy in high-risk intracranial PNET (1995) (0)
- New Approaches in Radiation Therapy (1989) (0)
- Experience with a CT Based Treatment Planning System. (1980) (0)
- Quantitative Analysis of the Effects of Iododeoxyuridine and Ionizing Radiation Treatment on the Cell Cycle Dynamics of DNA Mismatch Repair Deficient Human Colorectal Cancer Cells (2014) (0)
- 5-Iodo-2-Pyrimidinone-2′-Deoxyribose (IPdR, NSC-726188) pharmacokinetic study in F344 rats (2006) (0)
- The effect of ici 182,780 an anti-estrogen agent, on radiosensitivity of mcf-7 breast carcinoma cells irradiated in vitro. supported by an ASTRO research fellowship (1994) (0)
- 1075 : A Phase II Trial of Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Resectable or Unresectable Non-Metastatic Pancreatic Cancer (2006) (0)
- Iododeoxyuridine (IdUrd)-induced cytotoxicity and radiosensitivity involves the Base Excision Repair (BER) protein XRCC1 (2001) (0)
- The Pu/Robertson/Lawrence article reviewed (1995) (0)
- Combining cytostatic agents with radiation therapy for rapidly dividing head and neck tumors: Strategies for improved locoregional control (1993) (0)
- Correspondence re: J.A. Knol et al., Incorporation of 5-bromo-2-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion. Cancer Res., 55: 3687-3691, 1995. (1996) (0)
- Role of MutS (cid:1) in the Recognition of Iododeoxyuridine in DNA 1 (2003) (0)
- S17 07 TA – S-PHASE SPECIFIC RADIOSENSITIZERS: NEW EXPERIMENTAL AND CLINICAL APPROACHES TO OVERCOME TUMOR CELL REPOPULATION (1991) (0)
- Experience Using Fractionated Stereotactic Radiosurgery to Treat Large CNS Metastases (2013) (0)
- Local Control and Toxicity in Single-fraction and Fractionated Stereotactic Radiosurgery in the Treatment of Brain Metastases: A Case-Matched Analysis. (2016) (0)
- Editorial: 365 days of progress in radiation oncology (2023) (0)
- Tomotherapy: Inverse treatment planning for conformal radiotherapy (1993) (0)
- Surgical treatment of tuberculosis in the diabetic patient. (1961) (0)
- A reliable intensity modulated radiation therapy approach with multiple opposed lateral fields for head and neck tumors (2000) (0)
- P38 06 TP – IdUrd RADIOSENSITIZATION OF HUMAN GLIOBLASTOMA CELLS EXPOSED TO ACUTE AND CHRONIC GAMMA IRRADIATION (1991) (0)
- The indeterminate lung lesion. (1962) (0)
- The choice of dose levels for high dose rate (HDR) gynecologic brachytherapy (1990) (0)
- 2221 pRb alterations abrogate cell cycle control and increase apoptosis and radiosensitivity (1996) (0)
- Concomitant irradiation and intra-arterial 5-fluorouracil (5-FU) for liver metastase: Tumor response and liver tolerance (1981) (0)
- Hodgkin's disease: Dilemma in staging and treatment (1984) (0)
- Postresection CA 19-9 value as a prognostic factor: in response to the letter by Kilickap and Arslan. (2010) (0)
- Manpower issues and training program directions in radiation oncology. (1996) (0)
- Transit dose in high dose rate brachytherapy: Direct measurements and clinical implications (1992) (0)
- Histone deacetylase inhibitor enhances IUdR-mediated radiosensitization in human glioblastoma U251 cells (2007) (0)
- Intraoperative radiotherapy - “Where has it been and where is it going?” (1990) (0)
- Possible immunological aspects of radiation pneumonitis: Experimental investigations (1994) (0)
- In response to Dr. Deore et al. (1996) (0)
- The Outcome of Chemoradiotherapy for Anal Cancer in Immunocompetent versus Immunodeficient Patients (2008) (0)
- Computational modeling of the effect of the mismatch repair protein hMLH1 upon cell cycle responses and cytotoxicity of 5-iododeoxyuridine (IUdR) in colon cancer cells. (2007) (0)
- Cancer Therapy : Preclinical Differential Cellular Responses to Prolonged LDR-IR in MLH 1-Proficient and MLH 1-Deficient Colorectal Cancer HCT 116 Cells (2009) (0)
- 2124 Improving dose homogeneity in head and neck radiotherapy with custom 3-D compensation (1996) (0)
- Retirement or dismissal. (1963) (0)
- P16 23 MP – RADIOSENSITIVITY AND PLDR OF SMALL ROUND CELL TUMORS (1991) (0)
- Sequential comparison of ldr and hyperfractionated HDR EBRT for MAO (1991) (0)
- 1071: Rectal Toxicity following Permanent Prostate Brachytherapy with Dose Escalation to Biological Tumor Volumes (BTV) Identified with Prostascint and CT Scan Image Fusion (2004) (0)
- Advances in Brief The Mismatch Repair Protein , hMLH 1 , Mediates 5-Substituted Halogenated Thymidine Analogue Cytotoxicity , DNA Incorporation , and Radiosensitization in Human Colon Cancer Cells 1 (1999) (0)
- RADI-40. STEREOTACTIC RADIOSURGERY FOR BRAINSTEM METASTASES: AN ANALYSIS OF SINGLE FRACTION AND MULTI FRACTION TECHNIQUES (2019) (0)
- Radiation in Human Cervical Carcinoma Cells Expression of Ribonucleotide Reductase after Ionizing (2013) (0)
- Long term toxicity of mediastinal intraoperative radiotherapy (1990) (0)
- Locoregional tumor control in head and neck (H&N) cancer patients following hyperfractionated, accelerated radiotherapy with dose escalation (HARDE) (1994) (0)
- Pre-clinical toxicity and efficacy study of oral IPDR (QD X 14D) as a prodrug for IUDR-radiosensitization in U25 human glioblastoma xenografts (1998) (0)
- P15 07 MP – ADDING CONTINUOUS ESCALATION TO ACCELERATED HYPERFRACTIONATION FOR HEAD AND NECK CANCER (1991) (0)
- Three-dimensional treatment planning computer-based vs nomogram-based implant technique for prostate carcinoma (2000) (0)
- SU‐FF‐J‐39: Comparison of Patient Positioning Corrections For Prostate IMRT Patients Using Competing Image Guided Radiation Therapy Technologies (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Timothy James Kinsella?
Timothy James Kinsella is affiliated with the following schools:
